American arm of the Japanese company Sumitomo Pharma, based at Marlborough in Massachusetts, which traded as Sunovion Pharmaceuticals until the group's United States businesses were combined. Sells medicines for psychiatry and neurology including treatments for schizophrenia, bipolar depression and Parkinson's disease, together with respiratory products, and runs clinical development and commercial operations in the United States.
Aucun commentaire disponible.
Laissez votre note & commentaire